A significant leap forward in cancer treatment has been demonstrated by researchers at Johns Hopkins University and the University of Maryland School of Pharmacy. Their development of novel drugs targeting hypoxia-inducible factors 1 and 2 (HIF-1/2) – often called “master regulators” of cancer – has shown the potential for complete tumor elimination in mice when … Read more
The Aging-Cancer Nexus: How Targeting Cellular Stress Could Revolutionize Lung Cancer Treatment Lung cancer is responsible for nearly one in five cancer deaths globally. But what if the key to safer, more effective therapies wasn’t just about attacking the tumor itself, but about addressing the underlying cellular vulnerabilities exacerbated by aging? Emerging research reveals a … Read more
The fight against cancer is entering a new era, shifting from reactive treatment to proactive risk assessment. Scientists at the University of Geneva (UNIGE) have made a breakthrough in understanding *why* some cancers metastasize while others remain localized – a question that has plagued oncology for decades. Their work, published in Cell Reports, doesn’t just … Read more